The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PD

ConditionParkinson Disease

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40-80

SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

This study is a double blind comparative study examining the effectiveness of the transcutaneous auricular vagus nerve stimulation treatment on Parkinson's disease patients with depression. The investigators hypothesize that taVNS will improve depression and cortical activity in Parkinson's disease patients with depression.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Active Transcutaneous auricular vagus nerve stimulation
Sham Transcutaneous auricular vagus nerve stimulation

Treatment groups

30 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

The First Affiliated Hospital with Nanjing Medical University

Lead sponsor

The Second People's Hospital of Huai'an

Collaborator

Source ClinicalTrials.gov